106 related articles for article (PubMed ID: 22766564)
21. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.
Fromigué O; Hamidouche Z; Marie PJ
J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811
[TBL] [Abstract][Full Text] [Related]
22. Effects of atorvastatin on fine particle-induced inflammatory response, oxidative stress and endothelial function in human umbilical vein endothelial cells.
Zhao J; Xie Y; Jiang R; Kan H; Song W
Hum Exp Toxicol; 2011 Nov; 30(11):1828-39. PubMed ID: 21357632
[TBL] [Abstract][Full Text] [Related]
23. Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors.
Zineh I; Luo X; Welder GJ; Debella AE; Wessel TR; Arant CB; Schofield RS; Chegini N
Pharmacotherapy; 2006 Mar; 26(3):333-40. PubMed ID: 16503719
[TBL] [Abstract][Full Text] [Related]
24. Atorvastatin protects against angiotensin II-induced injury and dysfunction in human umbilical vein endothelial cells through bradykinin 2 receptors.
Zhang XS; Ren JH; Lu JP; Fan Y
J Cardiovasc Pharmacol; 2010 Aug; 56(2):171-6. PubMed ID: 20489655
[TBL] [Abstract][Full Text] [Related]
25. Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide.
Dayoub JC; Ortiz F; López LC; Venegas C; Del Pino-Zumaquero A; Roda O; Sánchez-Montesinos I; Acuña-Castroviejo D; Escames G
J Pineal Res; 2011 Oct; 51(3):324-30. PubMed ID: 21585521
[TBL] [Abstract][Full Text] [Related]
26. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.
Spyridopoulos I; Haendeler J; Urbich C; Brummendorf TH; Oh H; Schneider MD; Zeiher AM; Dimmeler S
Circulation; 2004 Nov; 110(19):3136-42. PubMed ID: 15520325
[TBL] [Abstract][Full Text] [Related]
27. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response.
Arazi SS; Genvigir FD; Willrich MA; Hirata MH; Dorea EL; Bernik M; Hirata RD
Clin Chim Acta; 2008 Jul; 393(2):119-24. PubMed ID: 18435918
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
29. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.
Liu XS; Zhang ZG; Zhang L; Morris DC; Kapke A; Lu M; Chopp M
J Cereb Blood Flow Metab; 2006 Jun; 26(6):787-96. PubMed ID: 16177809
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
Moon JH; Kang SB; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Metabolism; 2011 Jul; 60(7):930-40. PubMed ID: 20951395
[TBL] [Abstract][Full Text] [Related]
31. Atorvastatin affects several angiogenic mediators in human endothelial cells.
Dulak J; Loboda A; Jazwa A; Zagorska A; Dörler J; Alber H; Dichtl W; Weidinger F; Frick M; Jozkowicz A
Endothelium; 2005; 12(5-6):233-41. PubMed ID: 16410222
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
33. Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism.
Pramfalk C; Parini P; Gustafsson U; Sahlin S; Eriksson M
J Intern Med; 2011 Mar; 269(3):333-9. PubMed ID: 21083855
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin induces tissue transglutaminase in human endothelial cells.
Soehnlein O; Eskafi S; Schmeisser A; Kloos H; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Sep; 322(1):105-9. PubMed ID: 15313180
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.
Staedler D; Chapuis-Bernasconi C; Dehmlow H; Fischer H; Juillerat-Jeanneret L; Aebi JD
J Med Chem; 2012 Jun; 55(11):4990-5002. PubMed ID: 22533316
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies.
Yang PM; Liu YL; Lin YC; Shun CT; Wu MS; Chen CC
Cancer Res; 2010 Oct; 70(19):7699-709. PubMed ID: 20876807
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells.
Yang SS; Li R; Qu X; Fang W; Quan Z
Cell Immunol; 2012 Sep; 279(1):96-102. PubMed ID: 23103560
[TBL] [Abstract][Full Text] [Related]
38. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
39. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
Wagner AH; Schwabe O; Hecker M
Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
